New Patented Technology Determines Who Should Receive COVID-19 Vaccine First by Tracing Coronavirus “Super Distributors”

A new technology aims to determine which people should be first given the COVID-19 vaccine before the rest of the population to effectively stop the spread of the SARS-CoV-2 virus.

The technology developed by the Ehrlich Group (Ramat-Gan, Israel) was recently filed for a patent in the United Arab Emirates’ patent office, according to a report by the Jerusalem Post. The long-awaited COVID-19 vaccine is just months away from potentially curing the world from the SARS-CoV-2 virus, although it would take years to manufacture, distribute and vaccinate the entire world population.

Using data about the number of contacts and interactions by each individual, the new patented technology will establish priority guidelines for the vaccination of the population against COVID-19. The technology will trace "super-distributors” of the SARS-CoV-2 virus who will be given priority for administering the COVID-19 vaccine. The technology is based on the analysis of data collected from Israeli intelligence agencies or from various apps where users approve the use of their location data. By tracing and vaccinating super distributors of the SARS-CoV-2 virus, the chains of transmissions and infections within the community can be broken, making it possible to stop the spread of the SARS-CoV-2 virus even before the entire population is vaccinated, thus saving time and money, according to the Jerusalem Post report.

Related Links:
Ehrlich Group